| Financial Year |
March 31 2023 |
| Monetary Funds |
2,899,301,040.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
39,200,000.00 |
| Accounts Receivable |
8,121,301,411.39 |
| Advances to Suppliers |
2,192,505,258.56 |
| Other Receivables |
266,982,502.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,655,827.30 |
| Inventories |
12,860,218,475.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
19,950,000.00 |
| Other Current Assets |
121,971,435.22 |
| Total Current Assets |
26,739,339,318.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,488,800.00 |
| Long-term Equity Investment |
3,196,128,159.33 |
| Investment Properties |
518,465,270.00 |
| Fixed Assetes |
379,488,543.08 |
| Under-construction Projects |
461,914,643.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,947,794,264.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,088,183.40 |
| Deferred Income Tax Assets |
270,863,013.74 |
| Other Non-Current Assets |
2,346,429,122.37 |
| Sub-Total of Non-Current Assets |
13,519,171,427.56 |
| Total Assets |
40,258,510,746.37 |
| Short-Term Loans |
8,023,745,376.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,466,243,431.74 |
| Accounts Payable |
2,224,110,773.63 |
| Accounts Received In Advance |
12,207,983.46 |
| Employee Compensation Payable |
5,285,727.97 |
| Taxes Payable |
1,163,360,681.63 |
| Interest Payable |
-- |
| Dividend Payable |
456,643,794.32 |
| Other payables |
5,854,275,450.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,299,379,405.23 |
| Other Current Liabilities |
52,832,274.15 |
| Sub-Total of Current Liabilities |
22,536,110,521.54 |
| Long-term Loans |
5,226,679,080.40 |
| Bonds Payable |
45,301,000.00 |
| Long-Term Accounts Payable |
5,282,435,830.66 |
| Special Payable |
-- |
| Estimatied Liabilities |
84,733,098.58 |
| Deferred Income Tax Liabilities |
193,274,875.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,200,705,771.17 |
| Total Liabilities |
33,736,816,292.71 |
| Paid-In Capital(Or Share Stock) |
1,475,573,852.00 |
| Capital Surplus |
684,496,234.11 |
| Surplus Reserve |
533,571,580.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,773,737,413.48 |
| Minority Stockholder's Interest |
1,005,930,173.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,515,764,280.00 |
| Owner's Equity（Stockholder's Equity） |
6,521,694,453.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,258,510,746.37 |
